Recent emerging studies have indicated that TXNIP plays an important role in the pathogenesis of NAFLD and that targeting TXNIP may represent a therapeutic approach for treating steatohepatitis24. This evidence concerns the gene TXNIP and metabolic dysfunction-associated steatotic liver disease.